Lista de obras - Toril Holien - Dominio Público Uruguay

A method for measurement of drug sensitivity of myeloma cells co-cultured with bone marrow stromal cells

artículo científico publicado en 2013

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B

artículo científico publicado en 2015

Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors

artículo científico publicado en 2020

Addiction to c-MYC in multiple myeloma

artículo científico publicado en 2012

Artesunate shows potent anti-tumor activity in B-cell lymphoma

artículo científico publicado en 2018

BMPR2 inhibits activin and BMP signaling via wild-type ALK2

artículo científico publicado en 2018

Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone

artículo científico publicado en 2019

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.

artículo científico

Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC.

artículo científico publicado en 2011

Chemical, Physical and Biological Triggers of Evolutionary Conserved Bcl-xL-Mediated Apoptosis

artículo científico publicado en 2020

Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo

artículo científico publicado en 2018

CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesis

artículo científico publicado en 2010

Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan™.

artículo científico publicado en 2017

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids

artículo científico publicado en 2015

GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients

scientific article published on 06 November 2019

Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease

artículo científico publicado en 2015

HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase

artículo científico publicado en 2013

Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells

artículo científico publicado en 2016

Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells

artículo científico publicado en 2016

Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate

artículo científico publicado en 2013

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy.

artículo científico publicado en 2015

Monitoring multiple myeloma by quantification of recurrent mutations in serum.

artículo científico publicado en 2017

Oncogene addiction to c-MYC in myeloma cells

artículo científico publicado en 2012

Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics.

artículo científico publicado en 2015

Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis

artículo científico publicado en 2020

Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.

artículo científico publicado en 2011

TGF-β contamination of purified recombinant GDF15.

artículo científico publicado en 2017

Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells

artículo científico publicado en 2013

The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma

artículo científico publicado en 2015

The role of bone morphogenetic proteins in myeloma cell survival.

artículo científico publicado en 2014

c-Met signaling promotes IL-6-induced myeloma cell proliferation

artículo científico publicado en 2009

Lista de obras de Toril Holien

A method for measurement of drug sensitivity of myeloma cells co-cultured with bone marrow stromal cells

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B

Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors

Addiction to c-MYC in multiple myeloma

Artesunate shows potent anti-tumor activity in B-cell lymphoma

BMPR2 inhibits activin and BMP signaling via wild-type ALK2

Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.

Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC.

Chemical, Physical and Biological Triggers of Evolutionary Conserved Bcl-xL-Mediated Apoptosis

Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo

CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesis

Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan™.

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids

GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients

Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease

HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase

Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells

Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells

Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy.

Monitoring multiple myeloma by quantification of recurrent mutations in serum.

Oncogene addiction to c-MYC in myeloma cells

Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics.

Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis

Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.

TGF-β contamination of purified recombinant GDF15.

Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells

The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma

The role of bone morphogenetic proteins in myeloma cell survival.

c-Met signaling promotes IL-6-induced myeloma cell proliferation